Cipla Foundation has secured funding from the U.S. Government from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), through the United States Agency for International Development (USAID), to expand the national footprint of the patient-centric Central Chronic Medicines Dispensing and Distribution (CCMDD) programme. The funding follows the successful rollout of five CCMDD pick-up point facilities across Kwa-Zulu Natal.
A National Department of Health initiative, the CCMDD programme aims to improve access to chronic medication for stable patients who are dependent on the public sector. While the programme is already well established in South Africa, with about 1.9 million patients enrolled, this partnership with USAID will grow the Cipla Foundation CCMDD network of five units to 50 units over the next two years.
This expansion is already underway with deployment of the first four units. Having perfected the model over the past 12 months in Kwa-Zulu Natal, things are moving swiftly. With USAID’s support, Cipla Foundation recently landed four units in Johannesburg, in the greater Tembisa area (Ivory Park and Rabie Ridge). Following the rollout of these first units in the City of Johannesburg, which are operational as from this month, the next units will be deployed in Soweto and Orange Farm. This means that increasingly more patients with chronic illnesses across the country will have easier access to life-saving medication.
Paul Miller, CEO of Cipla South Africa, parent body of the Cipla Foundation, says “This is in line with Cipla’s purpose of Caring for Life. Through our primary healthcare initiative, Sha’p Left, the CCMDD initiative came as a natural expansion in providing access not to the few, but to the many. By ensuring convenience and access for patients, these facilities can improve patient adherence to chronic medication, while simultaneously reducing patient load and congestion at national health facilities.”
The Cipla Foundation Project will work closely with the Department of Health and other stakeholders to optimise enrolment into the CCMDD programme and maximise patient retention in the programme.